Biogen Inc (BIIB)

213.57 +1.64 (+0.77%) USD  |  NASDAQ  |  Jun 27, 16:00
214.04 +0.47 (+0.22%) After-Hours: 19:12
More

Biogen News

News

Headline
Wire
Time (ET)
Biogen stops clinical trial tracking Aduhelm
Yahoo
06/24 08:12
Market Chatter: Biogen Terminates Alzheimer's Drug Aduhelm Study Over Coverage Limits
MT Newswires
06/24 07:17
Biogen pulls plug on Aduhelm real-world study on coverage woes - Fierce Pharma
SA Breaking News
06/24 06:42
Executive Voice: Seasoned leader steers North Carolina toward growth
Yahoo
06/23 10:32
Biogen, Happify Health Team Up to Offer Digital Services for Multiple Sclerosis Patients
MT Newswires
06/22 11:56
Biogen Celebrates 20 Years of Caring Deeply
Yahoo
06/22 10:00
Biogen and Happify Health Collaborate to Support Multiple Sclerosis Patients on Digital Platform
Yahoo
06/22 09:00
Ionis (IONS), AstraZeneca's Amyloidosis Drug Meets Study Goals
Yahoo
06/21 09:32
European Patent Office Grants Patent Related to TECFIDERA® (Dimethyl Fumarate)
Yahoo
06/21 06:37
Wells Fargo names 50 stocks to short (or at least avoid)
SA Breaking News
06/19 09:00
Roche Alzheimer's Candidate Failure Hurts Lilly, Biogen
Yahoo
06/17 08:31
Roche’s Failed Alzheimer’s Trial Could Have Implications for Lilly, Biogen
Yahoo
06/16 09:52
Karyopharm Therapeutics' Shares Slide After Biogen Terminates 2018 Asset Purchase Agreement
Yahoo
06/15 16:52
Karyopharm Therapeutics Says Biogen Scraps KPT-350 Deal from 2018
MT Newswires
06/15 16:50
New Data Presented at Cure SMA Reveal Residual Unmet Needs in Young SMA Patients Treated With Gene Therapy and Suggest Further Potential of Using SPINRAZA® (nusinersen)
Yahoo
06/15 07:30
Ionis' (IONS) Angelman Syndrome Drug Gets FDA's Orphan Tag
Yahoo
06/14 13:00
The Biogen Foundation and Community Lab Celebrates 20 Years of Serving our Communities
Globe Newswire
06/14 07:30
Biogen, Sage to submit a single marketing application for depression candidate
SA Breaking News
06/13 09:34
Is Biogen a Bargain or a Bust?
Yahoo
06/09 11:15
7 No-Brainer Biotech Stocks to Add to Your Buy List
Yahoo
06/09 09:58
Biogen Bows Out of Conference Over 'COVID Considerations'
MT Newswires
06/08 12:36
Biogen pulls out of Jefferies Healthcare Conference citing COVID concerns
SA Breaking News
06/08 12:09
Biogen Inc.'s (NASDAQ:BIIB) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Yahoo
06/08 10:33
Biogen (BIIB) Inks Deal for Alectos' Parkinson's Disease Drug
Yahoo
06/07 08:51
Biogen Agrees to Develop, Commercialize Alectos Therapeutics' AL01811 for Parkinson's Disease
MT Newswires
06/06 08:33
Biogen inks licensing deal for Parkinson’s disease candidate
SA Breaking News
06/06 08:00
Biogen and Alectos Therapeutics Announce License and Collaboration Agreement for AL01811, a Novel GBA2 Inhibitor for the Potential Treatment of Parkinson’s Disease
Globe Newswire
06/06 07:30
Biogen, Bio-Thera Report Phase 3 Data for Tocilizumab Biosimilar Candidate
MT Newswires
06/03 12:23
Biogen and Bio-Thera Solutions Present Positive Phase 3 Data for Tocilizumab Biosimilar Candidate at the Annual European Congress of Rheumatology (EULAR 2022)
Globe Newswire
06/03 08:00
Biogen/Ionis tofersen slows decline in certain functions in ALS patients in new data
SA Breaking News
06/03 06:26
Biogen Phase 3 Trial Shows Clinical Benefit of Tofersen in ALS Patients
MT Newswires
06/03 05:50
New 12-Month Tofersen Data Presented at ENCALS Meeting Show Clinically Meaningful Benefit in People With SOD1-ALS
Globe Newswire
06/03 05:20
Sage (SAGE), Biogen (BIIB) Depression Drug Meets Study Goals
Yahoo
06/02 15:20
Biogen Inc. (BIIB) Down 4.8% Since Last Earnings Report: Can It Rebound?
Yahoo
06/02 11:31
Biogen, Samsung Bioepis' Byooviz Launches in US
MT Newswires
06/02 08:43
Biogen and Samsung Bioepis’ BYOOVIZ™ (ranibizumab-nuna) Launches in the United States
Yahoo
06/02 08:00
Sage Therapeutics And Biogen Tackle Depression — And Their Stocks Do The Same
Yahoo
06/01 16:10
Biotech Stock Roundup: BMY's Opdivo Updates, Pipeline Updates From REGN, BIIB
Yahoo
06/01 14:39
Sage Stock Rises on Postpartum Depression Drug Data
Yahoo
06/01 09:50
Biogen (BIIB), Denali Begin Mid-Stage Study on Parkinson's Drug
Yahoo
06/01 09:00
Sage Therapeutics, Biogen Say Phase 3 Study of Postpartum Depression Treatment Met Primary, Secondary Endpoints
MT Newswires
06/01 07:02
UPDATE 2-Sage-Biogen drug improves symptoms in postpartum depression study
Yahoo
06/01 06:50
Denali Therapeutics and Biogen Announce Initiation of Phase 2b Study of LRRK2 Inhibitor in Parkinson’s Disease
Yahoo
05/31 08:00
15 Best Drug Stocks To Buy Now
Yahoo
05/30 10:01
Ionis Pharmaceuticals' Angelman Syndrome therapy granted orphan drug status
SA Breaking News
05/26 13:41
INmune Bio (INMB) Down on Clinical Hold for Alzheimer's Study
Yahoo
05/25 12:07
Top Healthcare Stocks for June 2022
Yahoo
05/24 13:48
Biogen Needs a New CEO. Here Are Some Options.
Yahoo
05/24 11:13
Biogen Releases 2021 Year In Review, Disclosing Progress on Climate, Health and Equity
Yahoo
05/23 10:17
Office starts to rebound as Triangle remains hot market for growth
Yahoo
05/23 05:00
It's been a rocky two years for Mass. public companies. Here are some winners and losers.
Yahoo
05/19 14:16
How Many Biogen Inc. (NASDAQ:BIIB) Shares Do Institutions Own?
Yahoo
05/16 14:05
Biogen's Alex Cameron Discusses Biogen-MIT Biotech in Action
Yahoo
05/13 13:46
The Petri Dish: Biogen seeks accelerated approval for second Alzheimer's drug
Yahoo
05/12 05:24
Biogen Pops After Eisai Asks FDA To Approve A New Alzheimer's Treatment
Yahoo
05/10 16:13
How Are Biotech ETFs Reacting to These Q1 Earnings Releases?
Yahoo
05/10 14:05
Biogen Partner Eisai Files for Accelerated Approval of Alzheimer’s Drug
Yahoo
05/10 11:41
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Yahoo
05/10 06:20
Biogen Says Eisai Submits Biologics License Application for Lecanemab for Alzheimer's Disease to FDA
MT Newswires
05/10 04:24
EISAI COMPLETES ROLLING SUBMISSION TO THE U.S. FDA FOR BIOLOGICS LICENSE APPLICATION OF LECANEMAB FOR EARLY ALZHEIMER'S DISEASE UNDER THE ACCELERATED APPROVAL PATHWAY
PR Newswire
05/09 19:31
Lifshitz Law PLLC. Announces Investigations of Astra Space, Inc. (NASDAQ: ASTR), Biogen Inc, (NASDAQ: BIIB), Fennec Pharmaceuticals Inc. (NASDAQ: FENC), and Telos Corporation (NASDAQ: TLS)
Globe Newswire
05/09 11:57
Is This Growth Stock Defeated After Collapsing 22% in a Year?
Yahoo
05/07 10:30
The Zacks Analyst Blog Highlights Oracle, Union Pacific, Ford Motor, Biogen and Expedia Group
Yahoo
05/06 06:07
Biogen Partners With MedRhythms to Develop, Commercialize Potential Treatment for Gait Deficits in Multiple Sclerosis
MT Newswires
05/05 12:58
Ionis (IONS) Q1 Earnings & Sales Beat Estimates, Stock Rises
Yahoo
05/05 11:45
Analyst Upgrades and Research Reports for Oracle, Union Pacific, Ford & Others
Yahoo
05/05 11:32
Beset by challenges with its Alzheimer’s drug, Biogen pivots
Yahoo
05/05 07:38
Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis
Globe Newswire
05/05 07:30
1 Reason to Buy Biogen Now, and 1 Reason to Wait
Yahoo
05/05 06:00
Biotech Stock Roundup: BIIB & GILD's Earnings Update, VRTX Down on Regulatory News
Yahoo
05/04 13:39
--Morgan Stanley Adjusts Biogen's Price Target to $285 from $283, Keeps Overweight Rating
MT Newswires
05/04 12:46
--Oppenheimer Adjusts Biogen Price Target to $225 From $240, Maintains Outperform Rating
MT Newswires
05/04 11:09
--RBC Raises Price Target on Biogen to $251 From $244, Maintains Outperform Rating
MT Newswires
05/04 07:44
--Barclays Adjusts Biogen's Price Target to $210 From $219, Keeps Equalweight Rating
MT Newswires
05/04 07:18
--Wedbush Trims Biogen's Price Target to $185 From $188, Citing Aduhelm Wind-Down, Maintains Neutral Rating
MT Newswires
05/04 05:03
PRESS DIGEST- New York Times business news - May 4
Yahoo
05/04 02:37
Research Alert: CFRA Keeps Hold Opinion On Shares Of Biogen
MT Newswires
05/04 01:20
Drug companies are making an accounting change after the SEC cracked down on Biogen
Yahoo
05/03 15:04
Biogen's Quarterly Results Fall as Drugmaker Plans to Stop Selling Aduhelm; CEO to Step Down
MT Newswires
05/03 12:26
Biogen's 'Life After Aduhelm' Doesn't Include CEO Michel Vounatsos
Yahoo
05/03 11:18
Biogen (BIIB) Q1 Earnings Miss, Aduhelm Setback Leads to Rejig
Yahoo
05/03 10:55
Biogen Searches for New CEO in Wake of Struggles With Alzheimer’s Drug Launch
Yahoo
05/03 10:20
Biogen chief to step down after Alzheimer’s drug flops
Yahoo
05/03 09:48
Biogen plans $1B in cost-savings as CEO steps down
Yahoo
05/03 09:45
Sector Update: Health Care Stocks Mixed Premarket Tuesday
MT Newswires
05/03 09:19
Biogen Q1 Non-GAAP EPS, Revenue Drop; CEO Michel Vounatsos to Leave; Reaffirms 2022 Guidance
MT Newswires
05/03 08:53
Biogen Inc. (BIIB) Q1 Earnings Miss Estimates
Yahoo
05/03 08:25
Biogen's Q1 profit and revenue lag estimates, weighed down by Alzheimer's drug
Yahoo
05/03 08:10
Biogen CEO Michel Vounatsos to step down
Yahoo
05/03 07:45
Biogen CEO to step down; drugmaker pulls back on Alzheimer's drug Aduhelm
Yahoo
05/03 07:21
UPDATE 5-Biogen CEO to step down; drugmaker pulls back on Alzheimer's drug Aduhelm
Yahoo
05/03 07:10
Drug/Biotech Stocks Q1 Earnings Due on May 3: PFE, BIIB & More
Yahoo
05/02 15:55
Aduhelm woes, performance of multiple sclerosis drugs in focus for Biogen's Q1 earnings
SA Breaking News
05/02 13:27
Sage Therapeutics, Biogen Start Rolling Submission For Zuranolone In Major Depressive Disorder
Yahoo
05/02 12:58
Biogen, Scribe Therapeutics Expand Research Collaboration to Second Disease Target
MT Newswires
05/02 11:06
Notable earnings before Tuesday's open
SA Breaking News
05/02 10:26
Sage, Biogen Start Rolling Submission of New-Drug Application to US FDA for Major Depressive Disorder Drug Candidate
MT Newswires
05/02 10:20
Sage, Biogen start 'rolling submission' to FDA for depression drug
Yahoo
05/02 07:52
Sage Therapeutics and Biogen Initiate Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for Zuranolone for the Potential Treatment of Major Depressive Disorder (MDD)
Yahoo
05/02 06:30
The Zacks Analyst Blog Highlights Novo Nordisk, Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and Biogen
Yahoo
05/02 06:22
Biogen's CEO made $17.7M last year despite Alzheimer's drug woes
Yahoo
04/29 14:34
AbbVie (ABBV) Q1 Earnings Top, Competition Rises for Imbruvica
Yahoo
04/29 11:20
5 Big Pharma, Biotech Stocks Set to Beat Q1 Earnings Estimates
Yahoo
04/29 07:43
Biogen Inc. (BIIB) Gains But Lags Market: What You Should Know
Yahoo
04/28 17:50
--Wedbush Raises Biogen's Price Target to $188 From $185, Maintains Neutral Rating
MT Newswires
04/28 07:12
The Petri Dish: Biogen pulls Aduhelm in Europe, medtech startup joins unicorn club
Yahoo
04/28 05:26
Biogen Inc. (BIIB) Stock Sinks As Market Gains: What You Should Know
Yahoo
04/27 18:00
Big Biotech Firms Have Several Catalysts Lined Up, UBS Says
MT Newswires
04/27 16:13
Biotech Stock Roundup: GILD's COVID-19 Drug Update, AXSM Down on Regulatory News
Yahoo
04/27 12:44
UBS Adjusts Biogen Price Target to $244 From $269, Maintains Buy Rating
MT Newswires
04/27 12:26
Will Biogen (BIIB) Succeed in Beating Q1 Earnings Estimates?
Yahoo
04/27 08:35
Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Yahoo
04/26 15:01
Things Just Got Worse for Biogen
Yahoo
04/26 08:03
Biogen Fails To Convince Benefits Of Alzheimer's Drug To European Regulator
Yahoo
04/22 12:22
On Earth Day and Beyond, Biogen Drives Sustainable Production of Medicine
Yahoo
04/22 12:01
Biogen stock slides 2% after it withdraws authorization application with EU regulator
Yahoo
04/22 10:44
Biogen Withdraws European Marketing Authorization Application for Alzheimer's Disease Drug
MT Newswires
04/22 09:58
UPDATE 3-Biogen pulls application for Alzheimer's drug in Europe
Yahoo
04/22 09:41
Biogen Withdraws European Application For Alzheimer's Drug
Yahoo
04/22 09:25
Biogen Inc. (BIIB) Stock Moves -0.92%: What You Should Know
Yahoo
04/21 18:00
SVB Leerink Adjusts Biogen Price Target to $270 From $300, Maintains Outperform Rating
MT Newswires
04/21 12:42
Is Biogen Stock a Buy Now?
Yahoo
04/21 10:53
Down 16% Since October, Could This Stock Make a Turnaround?
Yahoo
04/21 10:37
Prothena (PRTA) Stock Gains 51% in a Year: What Lies Ahead?
Yahoo
04/21 10:13
Why Biogen Inc. (BIIB) is Poised to Beat Earnings Estimates Again
Yahoo
04/19 12:10
Why Biogen Stock Looks 'Too Good To Ignore,' According To One Analyst
Yahoo
04/18 16:03
Wells Fargo Upgrades Biogen to Overweight From Equalweight; Adjusts Price Target to $265 From $235
MT Newswires
04/18 07:41
Hasty approval for Alzheimer’s drug offers a cautionary tale
Yahoo
04/17 07:00
Biogen Inc. (BIIB) Stock Moves -0.67%: What You Should Know
Yahoo
04/14 18:00
INmune (INMB) Begins Dosing in Mid-Stage Study With AD Candidate
Yahoo
04/14 15:38
Former Sarepta, Biogen exec joins Editas as CEO
Yahoo
04/14 14:11
Biogen’s Aduhelm Crashes the Biotech Sector
Yahoo
04/13 07:36
--Barclays Adjusts Price Target for Biogen to $219 From $235, Maintains Equalweight Rating
MT Newswires
04/12 10:10
--Moody's Downgrades Biogen to Baa2 From Baa1; Outlook Negative
MT Newswires
04/11 17:13
Redefining What A Scientist Looks Like: Biogen Leaders Discuss the Importance of Women in STEM
Yahoo
04/11 12:01
How might the CMS decision on Biogen's Aduhelm impact other Alzheimer's candidates?
SA Breaking News
04/09 17:00
Biogen Inc. (BIIB) Gains As Market Dips: What You Should Know
Yahoo
04/08 17:50
REFILE-UPDATE 1-Alzheimer's drugmakers seek accelerated FDA review despite U.S. coverage decision
Yahoo
04/08 17:33
How Medicare 'Snuffed Out' Hope For Biogen's Controversial Alzheimer's Drug
Yahoo
04/08 16:06
10 Stocks to Watch on Friday
Yahoo
04/08 15:57
Eisai seeking accelerated FDA review of Alzheimer's drug after U.S. coverage decision
Yahoo
04/08 14:33
Should Biogen Investors Be Worried About Its Alzheimer's Drug?
Yahoo
04/08 13:50
It’s Lights Out for Biogen’s Aduhelm. But There’s Some Hope for Other Alzheimer’s Drugs.
Yahoo
04/08 11:15
Why Is Biogen (BIIB) Stock in the Spotlight Today?
Yahoo
04/08 10:01
Medicare to restrict coverage of Biogen’s Alzheimer’s drug
Yahoo
04/08 09:56
--Needham Adjusts Biogen's Price Target to $262 form $290, Keeps Buy Rating
MT Newswires
04/08 09:39
Sector Update: Health Care Stocks Edge Upward Premarket Friday
MT Newswires
04/08 09:17
Biogen (BIIB) Down as Medicare Limits Coverage for Aduhelm
Yahoo
04/08 08:59
Oppenheimer Adjusts Biogen's Price Target to $240 From $285, Maintains Outperform Rating
MT Newswires
04/08 08:43
Vir Biotechnology Appoints Johanna Friedl-Naderer as COO
MT Newswires
04/08 04:00
HP, Robinhood, Biogen Fall Premarket; Kroger, JetBlue Rise
Yahoo
04/08 04:00
Biogen Stock Is Falling After Medicare Limited Coverage of the Company’s Alzheimer’s Drug
Yahoo
04/07 22:42
Medicare severely restricts Biogen's Alzheimer's drug coverage
Yahoo
04/07 21:04
Lower enrollee premiums possible as Medicare stands by limitations on Biogen drug Aduhelm
Yahoo
04/07 19:53
Vir Biotechnology appoints Johanna Friedl-Naderer to COO
SA Breaking News
04/07 17:35
UPDATE 4-U.S. Medicare limits coverage for Biogen's Alzheimer's drug
Yahoo
04/07 17:33
Medicare Limits Coverage Policy for Biogen's Alzheimer's Drug -- Shares Slide After-Hours
MT Newswires
04/07 17:32
Biogen stock edges lower after Medicare restrictions on Aduhelm finalized
Yahoo
04/07 17:21
Biogen falls as Medicare officially limits coverage for Alzheimer’s drug
SA Breaking News
04/07 17:01
RBC Capital Adjusts Biogen's Price Target to $244 From $248, Maintains Outperform Rating
MT Newswires
04/06 07:57
Biogen Inc. (BIIB) Gains But Lags Market: What You Should Know
Yahoo
04/04 18:00
New Data at AAN 2022 Highlight Real-World Evidence from Biogen’s MS Portfolio and Emerging Research on Disease Progression
Globe Newswire
04/04 16:06
Wave Life gains most in more than a year after early-stage data for ALS drug
SA Breaking News
04/04 15:28
BIIB 4-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Biogen Inc. (BIIB) Investors with Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action
Globe Newswire
04/04 15:11
Advanced Micro Devices and Biogen have been highlighted as Zacks Bull and Bear of the Day
Yahoo
04/04 12:21
Bear of the Day: Biogen (BIIB)
Yahoo
04/04 06:20
10 Biotech Stocks to Buy According to Billionaire David E. Shaw
Yahoo
04/02 18:43
Biogen (BIIB) Plans to Start Aduhelm Confirmatory Study in May
Yahoo
03/31 12:19
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
Globe Newswire
03/30 19:40
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates
Yahoo
03/30 17:15
Biotech Stock Roundup: AXSM to Acquire JAZZ's Drug, IGMS Up on SNY Deal & More
Yahoo
03/30 13:29
Biogen Submits Final Study Protocol for Alzheimer's Injection to FDA
MT Newswires
03/30 07:51
Biogen submits Phase 4 study protocol for Alzheimer's disease drug
Yahoo
03/30 07:46
Biogen Submits Final Protocol for ADUHELM® (aducanumab-avwa) Phase 4 ENVISION Trial to FDA
Globe Newswire
03/30 07:30
Biogen Files the Final Design for Aduhelm’s Post-Approval Study
Yahoo
03/30 07:30
Biogen (BIIB), Ionis to End Early-Stage ALS Candidate Development
Yahoo
03/29 13:03
Prothena (PRTA) IND Application Gets FDA Clearance for AD
Yahoo
03/29 11:44
Biogen's ALS Drug Won't Move Forward After Trial Failures
Yahoo
03/29 10:27
BIIB 10-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Biogen Inc. (BIIB) Investors with Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action
Globe Newswire
03/29 09:36
Could Amylyx Pharmaceuticals Have a Blockbuster ALS Treatment?
Yahoo
03/29 05:45
The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug
Yahoo
03/29 05:30
Amylyx has a “very realistic shot”, Evercore says after FDA briefing docs on ALS drug
SA Breaking News
03/28 13:11
BofA Securities Adjusts Biogen's Price Target to $225 From $230, Keeps Neutral Rating
MT Newswires
03/28 10:28
Amylyx in focus as FDA releases briefing docs ahead of AdCom meeting on ALS therapy
SA Breaking News
03/28 10:17
Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday
MT Newswires
03/28 09:18
Biogen, Ionis Pharmaceuticals Discontinue Clinical Program for Amyotrophic Lateral Sclerosis Treatment; Shares Fall
MT Newswires
03/28 08:04
Biogen and Ionis Announce Topline Phase 1 Study Results of Investigational Drug in C9orf72 Amyotrophic Lateral Sclerosis
Globe Newswire
03/28 07:30
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ELMS, TAL, New Oriental, and Biogen and Encourages Investors to Contact the Firm
Globe Newswire
03/27 21:00
BIOGEN INC. (NASDAQ: BIIB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Biogen Inc. (NASDAQ: BIIB)
PR Newswire
03/23 11:43
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ELMS, TAL, New Oriental, and Biogen and Encourages Investors to Contact the Firm
Globe Newswire
03/21 21:00
LATEST FINDINGS ON LECANEMAB - CLINICAL EFFICACY, ARIA RATES, BIOMARKERS RELATIONSHIP TO CLINICAL OUTCOMES AND DOSING REGIMENS - PRESENTED AT AD/PD™ 2022 ANNUAL MEETING
PR Newswire
03/21 19:30
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims
Globe Newswire
03/21 19:16
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
PR Newswire
03/16 21:45
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Telos, Fennec, and Astra and Encourages Investors to Contact the Firm
Globe Newswire
03/16 21:00
Biogen Says Publication Containing Phase 3 Trial Data on Alzheimer's Drug Published in Journal
MT Newswires
03/16 12:37
Catalyst Biosciences Regains Rights to Dry AMD Treatment From Biogen
MT Newswires
03/16 12:12
Biogen Says Aduhelm Continues to Reduce Alzheimer's Disease Pathologies
MT Newswires
03/16 09:28
Biogen, Eisai Amend Collaboration Deal on Alzheimer's Disease Drug Aduhelm
MT Newswires
03/15 03:41
Biogen Starts Dosing of Spinraza in Phase 3b Study for Treatment of Spinal Muscular Atrophy
MT Newswires
03/14 08:46
Biogen Announces New Updates Across its SMA Research Program at 2022 MDA Conference
Globe Newswire
03/14 07:30
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
Globe Newswire
03/12 21:19
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against New Oriental, Biogen, Telos, and Fennec and Encourages Investors to Contact the Firm
Globe Newswire
03/11 21:00
Biogen to Present New Research at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD 2022)
Globe Newswire
03/11 16:30
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
PR Newswire
03/08 23:05
Biogen downgraded to hold at Stifel on questions on Alzheimer's therapy lecanemab
SA Breaking News
03/08 08:41
Stifel Downgrades Biogen to Hold From Buy, Adjusts Price Target to $223 From $304
MT Newswires
03/08 06:51
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Electric Last Mile, TAL, New Oriental Education, and Biogen and Encourages Investors to Contact the Firm
Globe Newswire
03/06 21:00
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
Globe Newswire
03/04 21:42
Sector Update: Health Care Investors Squaring Positions Ahead of Weekend Break
MT Newswires
03/04 15:49
Sector Update: Health Care Stocks Recovering This Afternoon
MT Newswires
03/04 13:56
Biogen's Partner Eisai Starts Application Process With Japan's Medicines Regulator for Lecanemab
MT Newswires
03/04 08:03
Biogen Inc. Company News: Berger Montague Investigates Securities Fraud Allegations Against Biogen, Inc. (NASDAQ: BIIB); Lead Plaintiff Deadline is April 8, 2022
PR Newswire
03/03 20:57
EISAI INITIATES SUBMISSION OF APPLICATION DATA UNDER THE PRIOR ASSESSMENT CONSULTATION SYSTEM IN JAPAN WITH THE AIM OF OBTAINING EARLY APPROVAL FOR INVESTIGATIONAL ANTI-AMYLOID BETA PROTOFIBRIL ANTIBODY LECANEMAB
PR Newswire
03/03 18:30
Biogen Could See Potential Higher Revenue, Share Price on Lifted Aduhelm Restrictions, Lecanemab Success, RBC Says
MT Newswires
03/03 15:52
Biogen's Shares Rise After RBC Upgrade
MT Newswires
03/03 14:16
Senators urge CMS not to restrict coverage of Biogen Alzheimer's drug Aduhelm
SA Breaking News
03/03 10:29
Biogen Upgraded by RBC to Outperform From Sector Perform, Price Target Boosted to $248 From $227, Amid Survey of Alzheimer's Doctors
MT Newswires
03/03 09:28
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
PR Newswire
02/28 22:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Telos, Fennec, and Astra Space and Encourages Investors to Contact the Firm
Globe Newswire
02/28 21:00
How Russia's invasion of Ukraine may impact pharma-biotech R&D
SA Breaking News
02/26 16:00
BIIB LAWSUIT ALERT: Levi & Korsinsky Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR Newswire
02/24 06:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against New Oriental Education, Biogen, Telos, and Fennec and Encourages Investors to Contact the Firm
Globe Newswire
02/23 21:00
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Biogen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 8, 2022 - (NASDAQ: BIIB)
PR Newswire
02/23 06:00
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
Globe Newswire
02/22 19:32
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Biogen Inc. (BIIB) Investors with Losses to Contact Firm’s Attorneys, Securities Class Action Filed
Globe Newswire
02/22 09:33
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Biogen Investors of a Lead Plaintiff Deadline of April 8, 2022
PR Newswire
02/22 06:00
BIOGEN DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $200,000 In Biogen To Contact Him Directly To Discuss Their Options
Globe Newswire
02/19 08:54
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Electric Last Mile, TAL Education, New Oriental, and Biogen and Encourages Investors to Contact the Firm
Globe Newswire
02/18 21:00
BIOGEN, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Biogen, Inc. in the United States District Court for the District of Massachusetts
Globe Newswire
02/18 09:57
BIIB SHAREHOLDER ALERT: Jakubowitz Law Reminds Biogen Shareholders of a Lead Plaintiff Deadline of April 8, 2022
PR Newswire
02/18 09:30
BIIB LAWSUIT ALERT: Levi & Korsinsky Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR Newswire
02/17 09:30
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
Globe Newswire
02/16 21:44
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Biogen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 8, 2022 - (NASDAQ: BIIB)
PR Newswire
02/16 09:30
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday
MT Newswires
02/16 09:14
Sage Therapeutics, Biogen Report Positive Data From Phase 3 Study of Zuranolone to Treat Major Depressive Disorder
MT Newswires
02/16 07:50
BIIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 8, 2022 in the Class Action Filed on Behalf of Biogen Inc. Shareholders
PR Newswire
02/15 09:30
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
PR Newswire
02/14 20:39
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Biogen Inc. (BIIB) Investors with Losses to Contact Firm’s Attorneys About Lead Plaintiff Opportunity in Securities Class Action
Globe Newswire
02/14 09:37
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Biogen Investors of a Lead Plaintiff Deadline of April 8, 2022
PR Newswire
02/14 09:30
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Telos, Fennec, and Astra Space and Encourages Investors to Contact the Firm
Globe Newswire
02/13 21:00
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Biogen Inc. (BIIB) Investors with Losses to Contact Firm's Attorneys, Securities Class Action Filed
PR Newswire
02/10 12:50
BIIB Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Biogen, Inc. Investors of Class Action and Encourages Investors to Contact the Firm
PR Newswire
02/09 10:00
Shareholder Alert: Robbins LLP Informs Investors Biogen, Inc. (BIIB) is Being Sued for Misleading Shareholders
Business Wire
02/09 05:03
HAGENS BERMAN BIIB ALERT: Investors in Biogen Inc. (BIIB) With Significant Losses Have Opportunity to Lead Securities Class Action
Globe Newswire
02/08 20:11
BIOGEN INC. (NASDAQ: BIIB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Biogen Inc. (NASDAQ: BIIB)
PR Newswire
02/08 18:09
Block & Leviton LLP Has Filed a Lawsuit Against Biogen, Inc. for Securities Law Violations
Globe Newswire
02/07 18:04
Biogen and Xbrane Announce Commercialization and License Agreement for Proposed Biosimilar Referencing CIMZIA® (Certolizumab pegol) with the Potential to Treat Rheumatoid Arthritis
Globe Newswire
02/07 16:05
UBS Adjusts Biogen Price Target to $269 From $333, Maintains Buy Rating
MT Newswires
02/07 12:42
Canaccord Genuity Adjusts Biogen's Price Target to $305 From $335, Maintains Buy Rating
MT Newswires
02/07 09:19
List prices of prescription medicines rise nearly 7% on average in 2022
SA Breaking News
02/05 12:00